Tracking physician promotional awareness--internationally and at a lower cost
IMS Health rolls out Global Message IQ service for syndicated market research
As part of the company’s Promo-Track service, which audits the effects (and effectiveness) of promotional campaigns by pharma manufacturers, IMS Health (Norwalk, CT) is now offering Global Message IQ. The service uses prescriber panels in six countries (now; it will have 18 countries by year-end) to audit promotional campaigns on an ongoing basis. Typical applications include product launch assessments, ongoing competitive analysis, or testing the effects of alternative promotional media (rep visits, e-detailing and the like).
“Typcially, manufacturers commission custom studies for audits like this,” says Liz Coyle, GM of commercial research at IMS Health. “That is limited to 200-300 respondents, and usually one nation’s market. And it’s expensive.” By contrast, Coyle says, the Promo-Track service offers 6,000 physicians (with more being added), and because of the syndicated (shared) service, the cost can be as little as 30% of that of a custom study.
The countries for which the service is available now are Canada, France, Italy, Spain, the UK, and the US.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
